Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Net Income (2021 - 2025)

Rxo (RXO) has disclosed Net Income for 5 consecutive years, with -$46.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income fell 84.0% year-over-year to -$46.0 million, compared with a TTM value of -$100.0 million through Dec 2025, up 65.52%, and an annual FY2025 reading of -$100.0 million, up 65.52% over the prior year.
  • Net Income was -$46.0 million for Q4 2025 at Rxo, down from -$14.0 million in the prior quarter.
  • Across five years, Net Income topped out at $44.0 million in Q2 2022 and bottomed at -$243.0 million in Q3 2024.
  • Average Net Income over 5 years is -$15.8 million, with a median of -$5.5 million recorded in 2022.
  • The sharpest move saw Net Income skyrocketed 150.0% in 2023, then tumbled 24200.0% in 2024.
  • Year by year, Net Income stood at $42.0 million in 2021, then plummeted by 109.52% to -$4.0 million in 2022, then surged by 150.0% to $2.0 million in 2023, then crashed by 1350.0% to -$25.0 million in 2024, then tumbled by 84.0% to -$46.0 million in 2025.
  • Business Quant data shows Net Income for RXO at -$46.0 million in Q4 2025, -$14.0 million in Q3 2025, and -$9.0 million in Q2 2025.